GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 96 filers reported holding GENERATION BIO CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $577,084 | -31.1% | 152,265 | 0.0% | 0.00% | – |
Q2 2023 | $837,458 | +27.5% | 152,265 | -0.3% | 0.00% | – |
Q1 2023 | $656,670 | +12.4% | 152,714 | 0.0% | 0.00% | – |
Q4 2022 | $584,232 | -24.9% | 152,714 | +0.5% | 0.00% | -100.0% |
Q3 2022 | $777,967 | -22.9% | 152,011 | -0.4% | 0.00% | 0.0% |
Q2 2022 | $1,008,852 | -8.3% | 152,574 | +0.0% | 0.00% | 0.0% |
Q1 2022 | $1,099,646 | +562.4% | 152,529 | +555.8% | 0.00% | – |
Q4 2021 | $166,000 | -70.5% | 23,259 | +3.6% | 0.00% | – |
Q3 2021 | $563,000 | -13.3% | 22,456 | -6.9% | 0.00% | -100.0% |
Q2 2021 | $649,000 | +3.5% | 24,121 | +9.5% | 0.00% | 0.0% |
Q1 2021 | $627,000 | +207.4% | 22,020 | +206.7% | 0.00% | – |
Q4 2020 | $204,000 | +0.5% | 7,179 | +9.5% | 0.00% | – |
Q3 2020 | $203,000 | – | 6,557 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
Corton Capital Inc. | 15,493 | $102,000 | 0.10% |